[AVDL] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
16-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 65.14%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 22,334 59,215 103,269 172,741 150,246 -
PBT -111,439 -93,145 -5,082 -38,582 -113,197 91,469 -9,718 50.13%
Tax 26,025 -15,816 -12,110 -5,356 -17,893 24,215 31,558 -3.16%
NP -137,464 -77,329 7,028 -33,226 -95,304 67,254 -41,276 22.19%
Tax Rate - - - - - -26.47% - -
Total Cost 137,464 77,329 15,306 92,441 198,573 105,487 191,522 -5.37%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 31.47 -56.11 -92.29 38.93 -27.47 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -2.29 -1.32 0.13 -0.89 -2.55 1.66 -1.00 14.80%
EPS Diluted -2.29 -1.32 0.13 -0.89 -2.55 1.61 -1.00 14.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.